Pignot Géraldine

doi.org/10.1016/j.euru… Final THOR-2 analysis: Oral erdafitinib significantly improved RFS vs intravesical chemotherapy and produced durable CRs in FGFR-altered HR & IR #NMIBC—bringing precision oncology into NMIBC care. @JimCatto @nikhilvasdevuro @PignotG @BladderCancerUS @IBCG_BladderCA @EUplatinum @Uroweb @UroOnc #FGFR #PrecisionOncology #UroOnc #ClinicalTrials

(Re)Découvrez @FocusMeeting : qualité du programme scientifique, experts nationaux et internationaux, toujours dans cette ambiance conviviale pour échanger sur nos spécialités ! youtu.be/ngifNhD-hBU A l'année prochaine pour Focus 2026 meets Switzerland 🇨🇭🇫🇷

🚨 Final THOR-2 results out in @EUplatinum - #Erdafitinib in FGFR-altered #NMIBC ✅ HR papillary NMIBC: • Median RFS not reached vs 11.6 mo with intravesical chemo • HR 0.25 (75% recurrence risk reduction) ✅ HR CIS ± papillary: • CR 94% at 8 wks | 81% at 32 wks • Median DoR 23.3 months ✅ Intermediate-risk NMIBC: • CR ~89% • Durable responses - median DoR not reached 👉Targeted systemic therapy showing real durability in IR and HR FGFR+ NMIBC #BladderCancer #TargetedTherapy @EUplatinum @oncodaily @urotoday @siadaneshmand @PignotG @nikhilvasdevuro @JimCatto @JNJInnovation

🇫🇷 I would like to thank all the patients, also the investigators, also @GETUG_Unicancer @AFUrologie for this huge effort. 🔑 EFFICACY END POINTS ARE AWAITED...

🇫🇷 GETUG-AFU 30 phase 2 randomized trial : - For patients with pathological high-risk MIBC, adjuvant RT is Safe and Feasible - All patients received the full prescribed dose without early termination or discontinuation. - Low rates of Gi / Gu acute toxicity were observed!

🎙️ EAU Podcast Episode - Dr. Silvia Secco (IT), Dr. Rianne Lammers (NL) and Dr. Guido Cereda (IT) share open reflections on how imposter syndrome shows up across a urological career - from trainees to senior clinicians. #WomeninUrology 🎧 Listen 👇 uroweb.org/education-even…

Clinical questions and real-world challenges at #BLADDR25. From staging and residual disease to PLND decisions, AI, rare histologies and applying trial data to elderly patients, a 90-minute deep dive with @prashantpatel, @UroMoschini, @PignotG, @bkonety, @achoud72 and Rob Jones @OncoAlert mirrorsmed.org

Excellent talk by @Ric_Campi on adjuvant RCC setting with thoughtful comments on multi-D strategy & shared decision making! @OncoAlert @mirrorsmed @b_szabados @Uromigos @mtsiatas @MichalisLiontos @spsutkaMD @EvanHallMD @drdanielvargas @cdanicas @PavlosMsaouel @LauraBukavinaMD

🎬 Day 1 of GLOBAL FORUM 2025! We’re kicking off #RENALC25 with an interactive, case-based debate on T1 renal tumours 💥 🩺 Surgery (@PignotG) 💥 SBRT (Peter Hoskin) ❄️ Cryoablation (Axel Bex) 👀 Active surveillance (@Ric_Campi) Which approach would YOU choose? Looking forward to 2 days full of expert insights & practical takeaways! @OncoAlert @mirrorsmed #KidneyCancer #RenalCellCarcinoma #OncoTwitter

Day 1 of GLOBAL FORUM 2025! Kicking off #RENALC25 with an interactive, case-based debate on T1 renal tumours: surgery (@PignotG ), SBRT (Peter Hoskin), cryoablation (Axel Bex) or active surveillance (@Ric_Campi ), what would you choose? Looking forward to the next couple of days packed with expert insights, debates and practical takeaways! @OncoAlert mirrorsmed.org

🧠 Live from #CFU2025 @AFUrologie with the Prostate team 🎈

Important new data from @EliLillyandCo presented at @AACR @theNCI @EORTC 2025 👉 independent validation of heterogeneous membranous NECTIN-4 expression in UC! NECTIN-4 was only detected in 113/176 EV-naïve UC specimens (primary + metastatic), app. 1/3 is NECTIN-4 negative. Heterogeneous expression of NECTIN-4. This is the first big pharma dataset confirming what many groups have observed 👉 that NECTIN-4 is not ubiquitously expressed! Consistent with prior academic data - incl. our own work @CCR_AACR PMID: 36534531 - great overview of NECTIN-4 expression in UC reviewed by @EmanueleCrupi et al. @JCOPO_ASCO PMID:39626158 Given the similar efficacy seen for EVP and anti-HER2 DV + PD-1, the field clearly needs validated biomarkers for future (m)UC Tx development in the sense of precision oncology! Will be exciting to see how/ if this impacts Lilly’s anti-NECTIN-4 ADC programs. Thoughts from the #UromigosLive meeting? @Markuseckstein3 @ViktorGruenwald @JoshMeeks @KuppeChristoph @IEO_HolzelLab @ASCO @JCO_ASCO @OncoAlert @urotoday @PTarantinoMD @Uroweb @drenriquegrande @PGrivasMDPhD @amerseburger @DrYukselUrun @tompowles1 @Uromigos @montypal @DrChoueiri @neerajaiims @shilpaonc @sonpavde @DrRosenbergMSK @Dr_Aggen @jonchou05

Novembre au Masculin | Messieurs, votre santé mérite toute votre attention ⚠️ 🔵 Troubles de l'érection, cancer de la prostate, cancer du testicule, troubles de l'éjaculation, problèmes de fertilité… Beaucoup d'hommes sont encore réticents à consulter, souvent par pudeur, parfois par manque d'information. Pour remédier à cela, l'AFU propose cette année une série de 4 lives sur la santé urologique masculine. Pour en savoir + : fb.me/e/iVH8mSp3z #BrisonsLesTabous #NovembreAuMasculin Accord healthcare | @Bayer_FR | Ipsen

It has been a terrific meeting, thank you for having me! Looking forward to many more collaborations between France and Spain.

👀Looking forward to speaking tomorrow about surgical optimization of #radicalcystectomy 📌FOCUS: France meets Spain 🇫🇷🇪🇸 🤩Happy to be with great friends @OncoBellmunt @Achard_Verane @BenjaminPradere @drenriquegrande @MRoupret

Packed room and ✨✨ superstar panel for the bladder session @OncoBellmunt @drenriquegrande @BenjaminPradere @MRoupret @FocusMeeting 🇫🇷🇪🇸 This is Focus!!

@FocusMeeting it’s tomorrow at the Pierre Baudis Convention Center #Toulouse ! With our presidents @Ecastromarcos et @kbensalah35🇪🇸🇫🇷 #focus2025meetsSpain #urology #oncology #radiotherapy @jbbeauval @PignotG @GPloussard @PouesselD @RoubaudG @MRoumiguie @PaulSargos

Let's go for @FocusMeeting to optimize our treatments in onco-urology! This year, FOCUS meets Spain 🇪🇸💃 Opening session by our presidents: Elena Castro and Karim Bensalah. What an opportunity to bring together the best international experts. @GPloussard @PaulSargos

Claim your spot for #RENALC25, an interactive meeting translating the latest evidence on renal cell cancer into clinical practice! ➡️Register here: tinyurl.com/487622jz and join us on December 3rd, in Lisbon or online! 🇵🇹💻 @PignotG @Ric_Campi @OncoAlert

Welcome to our house 🏡